Genetics and Diabetic Nephropathy
暂无分享,去创建一个
[1] G. Chatellier,et al. Association between high von Willebrand factor levels and the Thr789Ala vWF gene polymorphism but not with nephropathy in type I diabetes , 2000 .
[2] A. Solini,et al. Polymorphisms of angiotensin-converting enzyme and angiotensinogen genes in type 2 diabetic sibships in relation to albumin excretion rate. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[3] L. Groop,et al. Heritability of albumin excretion rate in families of patients with Type II diabetes , 1999, Diabetologia.
[4] K. Yamada,et al. Association of an (A–C)n dinucleotide repeat polymorphic marker at the 5′‐region of the aldose reductase gene with retinopathy but not with nephropathy or neuropathy in Japanese patients with Type 2 diabetes mellitus , 1999, Diabetic medicine : a journal of the British Diabetic Association.
[5] J. Gross,et al. Familial clustering of diabetic nephropathy in Brazilian type 2 diabetic patients. , 1999, Diabetes.
[6] A. Maxwell,et al. Risk of developing diabetic nephropathy is not associated with synergism between the angiotensin II (type 1) receptor C1166 allele and poor glycaemic control. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[7] J. Ménard,et al. Renal changes on hyperglycemia and angiotensin-converting enzyme in type 1 diabetes. , 1999, Hypertension.
[8] R. Holman,et al. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .
[9] T. Lehtimäki,et al. Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism and Diabetic Albuminuria in Patients with NIDDM Followed Up for 9 Years , 1998, Nephron.
[10] P. Talmud,et al. Effect of angiotensin-converting enzyme (ACE) gene polymorphism on progression of renal disease and the influence of ACE inhibition in IDDM patients: findings from the EUCLID Randomized Controlled Trial. EURODIAB Controlled Trial of Lisinopril in IDDM. , 1998, Diabetes.
[11] R. Eaton,et al. Z-2 microsatellite allele is linked to increased expression of the aldose reductase gene in diabetic nephropathy. , 1998, The Journal of clinical endocrinology and metabolism.
[12] D. Moczulski,et al. Major susceptibility locus for nephropathy in type 1 diabetes on chromosome 3q: results of novel discordant sib-pair analysis. , 1998, Diabetes.
[13] H. Parving,et al. Diabetic nephropathy and the insertion/deletion polymorphism of the angiotensin-converting enzyme gene. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[14] R. Hanson,et al. Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Pima Diabetes Genes Group. , 1998, Diabetes.
[15] D. Moczulski,et al. Diabetic nephropathy is associated with AGT polymorphism T235: results of a family-based study. , 1998, Hypertension.
[16] J. Staessen,et al. The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular‐renal risk , 1997, Journal of hypertension.
[17] D. Dunger,et al. Lack of association of angiotensin II type 1 receptor gene polymorphism with diabetic nephropathy in insulin‐dependent diabetes mellitus , 1997, Diabetic medicine : a journal of the British Diabetic Association.
[18] O. B. O. T. I. Group,et al. Clustering of albumin excretion rate abnormalities in Caucasian patients with NIDDM , 1997, Diabetologia.
[19] G Chatellier,et al. Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group. , 1997, The Journal of clinical investigation.
[20] M. Hibberd,et al. Polymorphism in the 5′-End of the Aldose Reductase Gene Is Strongly Associated With the Development of Diabetic Nephropathy in Type I Diabetes , 1997, Diabetes.
[21] A. Kaider,et al. Evaluation of risk factors for the development of nephropathy in patients with IDDM: insertion/deletion angiotensin converting enzyme gene polymorphism, hypertension and metabolic control , 1997, Diabetologia.
[22] L. Tarnow,et al. Genetics of diabetic nephropathy. , 1996, Journal of the American Society of Nephrology : JASN.
[23] F. Cambien,et al. Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study , 1996, BMJ.
[24] H. Parving,et al. Nephrology Dialysis Transplantation Angiotensin-II type 1 receptor gene polymorphism and diabetic microangiopathy , 2005 .
[25] W. Sheu,et al. Quantitative trait locus mapping of human blood pressure to a genetic region at or near the lipoprotein lipase gene locus on chromosome 8p22. , 1996, The Journal of clinical investigation.
[26] L. Tarnow. Genetic pattern in diabetic nephropathy. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[27] S. Kawazu,et al. Association analyses of the polymorphisms of angiotensin-converting enzyme and angiotensinogen genes with diabetic nephropathy in Japanese non-insulin-dependent diabetics. , 1996, Metabolism: clinical and experimental.
[28] H. Scheffer,et al. Association between angiotensin-converting-enzyme gene polymorphism and failure of renoprotective therapy , 1996, The Lancet.
[29] I. Stratton,et al. U.K. Prospective Diabetes Study. XV: Relationship of renin-angiotensin system gene polymorphisms with microalbuminuria in NIDDM. , 1995, Kidney international.
[30] I. Ichikawa,et al. Role of the deletion of polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. , 1995, The Journal of clinical investigation.
[31] R. Trevisan,et al. Genetic factors in the development of diabetic nephropathy. , 1995, The Journal of laboratory and clinical medicine.
[32] J E Tooke,et al. Microvascular Function in Human Diabetes: A Physiological Perspective , 1995, Diabetes.
[33] K. Lam,et al. An (A-C)n dinucleotide repeat polymorphic marker at the 5' end of the aldose reductase gene is associated with early-onset diabetic retinopathy in NIDDM patients. , 1995, Diabetes.
[34] T. Ogihara,et al. Angiotensin I-Converting Enzyme Gene Polymorphism Is Associated With Myocardial Infarction, but Not With Retinopathy or Nephropathy, in NIDDM , 1995, Diabetes Care.
[35] J. Connell,et al. Polymorphisms in angiotensin-converting-enzyme gene and progression of IgA nephropathy , 1995, The Lancet.
[36] J. Ménard,et al. Angiotensin-converting enzyme gene polymorphism has no influence on the circulating renin-angiotensin-aldosterone system or blood pressure in normotensive subjects. , 1995, Circulation.
[37] J. Connell,et al. Enhanced pressor response to angiotensin I in normotensive men with the deletion genotype (DD) for angiotensin-converting enzyme. , 1995, Hypertension.
[38] A. Krolewski,et al. Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus. , 1995, The New England journal of medicine.
[39] H. Parving,et al. Lack of Relationship Between an Insertion/Deletion Polymorphism in the Angiotensin I–Converting Enzyme Gene and Diabetic Nephropathy and Proliferative Retinopathy in IDDM Patients , 1995, Diabetes.
[40] E. Ritz,et al. Association of ACE gene polymorphism and diabetic nephropathy? The Diabetic Nephropathy Study Group. , 1995, Kidney international.
[41] B. Feldt-Rasmussen,et al. Effect of low-dose heparin on urinary albumin excretion in insulin-dependent diabetes mellitus , 1995, The Lancet.
[42] H. Parving,et al. The insertion/deletion polymorphism in the angiotensin I-converting enzyme gene predicts the progression of diabetic nephropathy during ACE inhibition in insulin dependent diabetic patients , 1995 .
[43] G. Watts,et al. Role of glycaemic control in development of microalbuminuria in patients with insulin dependent diabetes , 1994, BMJ.
[44] L. Tiret,et al. Plasma Level and Gene Polymorphism of Angiotensin‐Converting Enzyme in Relation to Myocardial Infarction , 1994, Circulation.
[45] L. Tiret,et al. Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. , 1994, Hypertension.
[46] H. Schunkert,et al. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. , 1994, The New England journal of medicine.
[47] A. Krolewski,et al. Genetic Predisposition to Diabetic Nephropathy: Evidence for a Role of the Angiotensin I–Converting Enzyme Gene , 1994, Diabetes.
[48] F. Cambien,et al. Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[49] F. Cambien,et al. Relationships Between Angiotensin I Converting Enzyme Gene Polymorphism, Plasma Levels, and Diabetic Retinal and Renal Complications , 1994, Diabetes.
[50] R. Bain,et al. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. , 1993, The New England journal of medicine.
[51] M. B. Perryman,et al. Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy , 1993, The Lancet.
[52] A. Marian,et al. Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death , 1993, The Lancet.
[53] S. Genuth,et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.
[54] J. Nyengaard,et al. Hyperglycemic Pseudohypoxia and Diabetic Complications , 1993, Diabetes.
[55] G. Remuzzi,et al. Heterogeneous nature of renal lesions in type II diabetes. , 1993, Journal of the American Society of Nephrology : JASN.
[56] Steven C. Hunt,et al. Molecular basis of human hypertension: Role of angiotensinogen , 1992, Cell.
[57] Philippe Amouyel,et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction , 1992, Nature.
[58] L. Tiret,et al. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. , 1992, American journal of human genetics.
[59] A. Fitzgerald,et al. Prospective Study of Microalbuminuria as Predictor of Mortality in NIDDM , 1992, Diabetes.
[60] H. Parving,et al. Is diabetic nephropathy an inherited complication? , 1992, Kidney international.
[61] K. Earle,et al. Familial clustering of cardiovascular disease in patients with insulin-dependent diabetes and nephropathy. , 1992, The New England journal of medicine.
[62] P Corvol,et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. , 1990, The Journal of clinical investigation.
[63] E. G. Erdös,et al. Angiotensin I converting enzyme and the changes in our concepts through the years. Lewis K. Dahl memorial lecture. , 1990, Hypertension.
[64] E. Seaquist,et al. Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. , 1989, The New England journal of medicine.
[65] F. Cambien,et al. Familial resemblance of plasma angiotensin-converting enzyme level: the Nancy Study. , 1988, American journal of human genetics.
[66] J. Ménard,et al. Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. , 1988, BMJ.
[67] H. Danielsen,et al. Acute and Long‐term Renal Effects of Angiotensin Converting Enzyme Inhibition in Normotensive, Normoalbuminuric Insulin‐dependent Diabetic Patients , 1988, Diabetic medicine : a journal of the British Diabetic Association.
[68] J. Flier,et al. Epidemiologic approach to the etiology of type I diabetes mellitus and its complications. , 1987, The New England journal of medicine.
[69] H. Keen,et al. Raised arterial pressure in parents of proteinuric insulin dependent diabetics. , 1987, British medical journal.
[70] M. Marre,et al. Converting enzyme inhibition and kidney function in normotensive diabetic patients with persistent microalbuminuria. , 1987, British medical journal.
[71] B. Brenner,et al. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. , 1986, The Journal of clinical investigation.
[72] Y. Taguma,et al. Effect of captopril on heavy proteinuria in azotemic diabetics. , 1985, The New England journal of medicine.
[73] G. Viberti,et al. Microalbuminuria Predicts Mortality in Noninsulin‐dependent Diabetes , 1984, Diabetic medicine : a journal of the British Diabetic Association.
[74] C. Mogensen,et al. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. , 1984, The New England journal of medicine.
[75] N. Lassen,et al. Hemodynamic factors in the genesis of diabetic microangiopathy. , 1983, Metabolism: clinical and experimental.
[76] B. Brenner,et al. Glomerular hemodynamics in experimental diabetes mellitus. , 1981, Kidney international.
[77] A. Sastre,et al. Serum angiotensin-converting enzyme: elevations in diabetes mellitus. , 1980, Annals of internal medicine.
[78] T. Lohmeier,et al. Control of glomerular filtration rate by renin-angiotensin system. , 1977, The American journal of physiology.
[79] A. Michael,et al. Studies of the Rate of Regression of the Glomerular Lesions in Diabetic Rats Treated with Pancreatic Islet Transplantation , 1975, Diabetes.
[80] R. Unger,et al. Studies of muscle capillary basement membranes in normal subjects, diabetic, and prediabetic patients. , 1968, The Journal of clinical investigation.
[81] R. Hanson,et al. Familial Factors in Diabetic Nephropathy , 2000 .
[82] S. Hadjadj,et al. Contribution of Angiotensin I Converting Enzyme I/D polymorphism to the development and progression of diabetic nephropathy in type 1 diabetes: a 6-year follow-up observational study , 1999 .
[83] T. Ogihara,et al. Meta-analysis of association of insertion/deletion polymorphism of angiotensin I-converting enzyme gene with diabetic nephropathy and retinopathy , 1998, Diabetologia.
[84] K. Thai,et al. Angiotensin converting enzyme gene polymorphism and renal hemodynamic function in early diabetes. , 1997, Kidney international.
[85] J. Staessen,et al. The insertion/deletion polymorphism of the angiotensin-converting enzyme gene and car-diovascular-renal risk : a meta-analysis , 1997 .
[86] H. Hemmi,et al. Angiotensin-converting enzyme polymorphism and development of diabetic nephropathy in non-insulin-dependent diabetes mellitus. , 1995, Nephron.
[87] B. Brenner,et al. Hemodynamically mediated glomerular injury and the progressive nature of kidney disease. , 1983, Kidney international.
[88] J. Vane. Sites of Conversion of Angiotensin I , 1972 .